|
Status |
Public on Mar 31, 2018 |
Title |
Human OCI-AML3 cells: Control vs. Atg5-shRNA or NPM1-shRNA inducibly expressed |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Transcriptional profiling of human OCI-AML3 cells stably expressing inducibly Atg5 shRNA or NPM1-shRNA Goal was to determine the effects of knockdown of Atg5 or NPM1 on global ES gene expression of human Leukemia OCI-AML3 cells.
|
|
|
Overall design |
Control (Dox-) vs. inducible knock down of Atg5 (Dox+) or NPM1 (Dox+) by doxycycline. Biological replicates: 3 control replicates, Atg5-shRNA 2 replicates, NPM1-shRNA 3 replicates
|
|
|
Contributor(s) |
Ji X, huang M |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Mar 13, 2015 |
Last update date |
Nov 27, 2018 |
Contact name |
Min Huang |
E-mail(s) |
minhuang@stanford.edu
|
Organization name |
Stanford Cancer Institute
|
Department |
Internal Medicine
|
Lab |
Beverly Mitchell
|
Street address |
265 Campus Drive
|
City |
Stanford |
State/province |
CA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platforms (1) |
GPL13607 |
Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Feature Number version) |
|
Samples (8)
|
GSM1634045 |
Control OCI-AML3 Cell without doxycycline Replicate 1 |
GSM1634046 |
Control OCI-AML3 Cell without doxycycline Replicate 2 |
GSM1634047 |
Control OCI-AML3 Cell without doxycycline Replicate 3 |
GSM1634048 |
OCI-AML3 cells: Atg5-shRNA inducibly expressed by doxycycline for 6 days-replicate 1 |
GSM1634049 |
OCI-AML3 cells: Atg5-shRNA inducibly expressed by doxycycline for 6 days-replicate 2 |
GSM1634050 |
OCI-AML3 cells: NPM1-shRNA inducibly expressed by doxycycline for 6 days-replicate 1 |
GSM1634051 |
OCI-AML3 cells: NPM1-shRNA inducibly expressed by doxycycline for 6 days-replicate 2 |
GSM1634052 |
OCI-AML3 cells: NPM1-shRNA inducibly expressed by doxycycline for 6 days-replicate 3 |
|
Relations |
BioProject |
PRJNA278297 |